DalsnaFinance

Innate Pharma completes enrollment in IPH4502 phase 1 study

Markets Investing.com By Investing.com 21 Jul 2026 05:04 1 min read
Innate Pharma completes enrollment in IPH4502 phase 1 study

Innate Pharma completes enrollment in IPH4502 phase 1 study

Innate Pharma completes enrollment in IPH4502 phase 1 study

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.